Robert Redfield insider trades

Open-market stock purchases and sales by Robert Redfield, Chief Medical Officer at Traws Pharma, Inc, from SEC Form 4 filings since Apr 1, 2024.

Recent trades

DateStockTradeValue
Jul 9, 2026TRAW Traws Pharma, IncBought (not open market)—
Mar 8, 2026TRAW Traws Pharma, IncBought (not open market)—
Dec 12, 2025TRAW Traws Pharma, IncBought (not open market)—
Dec 12, 2025TRAW Traws Pharma, IncBought (not open market)—
Oct 12, 2025TRAW Traws Pharma, IncBought (not open market)—

Companies traded

  • TRAW Traws Pharma, Inc: other filings, last Jul 9, 2026

Get free alerts when Robert Redfield files a new trade →